Tripor – Glenmark Pharmaceuticals

Registered App ID 4723933 Class 5 Word

Trademark information

IP India · live record
Application ID
4723933
Status
Registered
Sub status
Not Applicable
Date of application
29 October 2020
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
29 October 2030

Goods & services

Class 5

Class 5PHARMACEUTICAL, MEDICINAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS, NUTRACEUTICAL PREPARATIONS FOR THERAPEUTIC OR MEDICAL PURPOSES, NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS

PR details

GLENMARK PHARMACEUTICALS LTD., B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026, BODY INCORPORATE, (Body Incorporate)

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 29 Oct 2020
2 Reply to Exam Report (MIS-R) 03 Dec 2020
3 Reply to Exam Report (MIS-R) 03 Dec 2020
4 Authorization Letter 30 Apr 2022
5 Authorization Letter 05 Jul 2022
6 Authorization Letter 27 May 2023
7 Authorization Letter 07 Oct 2023
8 Journal Copy 18 Nov 2023
9 Certificate 14 Mar 2024

Correspondence and notices

1 EXAMINATION REPORT 10683353 13 Nov 2020
2 Hearing Notice (Show Cause) 13186464 15 Mar 2022
3 Hearing Notice (Show Cause) 13543319 25 May 2022
4 Hearing Notice (Show Cause) 15002644 24 Mar 2023
5 Hearing Notice (Show Cause) 16008650 11 Sep 2023
6 Tribunal Accepted Notice for : 4723933 16212473 · 6258062 09 Oct 2023

Frequently asked questions

Tripor was applied for on 29 October 2020.

The application was filed by Glenmark Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Tripor is 4723933.

Trademark attorney Vishesh And Associates.